Antoine Bonnet

Vannes, FR 
Vannes, FR 

Overview

Antoine Bonnet practices practicing medicine in Vannes, France.

His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Acute Myeloid Leukemia (AML).

He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Vannes, France
Other Locations
UMR CNRS 7266 LIENSs, Avenue Michel Crépeau, La Rochelle, 17042, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drugs: Ibrutinib, Venetoclax
Study Phase: Phase 2
A Phase II Open-label Study Evaluating Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma
A Phase II Open-label Study Evaluating Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: February 19, 2026
Intervention Type: Drug
Study Drug: Valemetostat tosylate
Study Phase: Phase 2
View 1 Less Clinical Trial

25 Total Publications

Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.
Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.
Journal: British journal of haematology
Published: May 05, 2026

Frequently Asked Questions about Antoine Bonnet

Is Antoine Bonnet a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Antoine Bonnet is classified as an Experienced expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antoine Bonnet participate in research or clinical trials?

Yes. Antoine Bonnet has published 25 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Antoine Bonnet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bonnet's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile